The scientists aim to determine why some people suffer serious illness and even death when infected with influenza while others suffer only mild to moderate symptoms. The research is published in a special joint issue of the journals Genetics and G3: Genes, Genomes, Genetics, both publications of the Genetics Society of America.
The research was conducted within the Pacific Northwest Regional Center for Excellence (PNWRCE) for Biodefense and Emerging Infectious Diseases, a consortium of investigators with extensive expertise, and basic and translational research capacity directed at a broad range of pathogens. The cooperative effort has the goal of combating emerging or re-emerging infectious diseases that pose a serious threat to human health. The director of the PNWRCE is Jay Nelson, Ph.D., the founder and director of the Vaccine and Gene Therapy Institute at OHSU.
For decades, mice have played a key role in developing new treatments from the discovery of penicillin to the creation of polio vaccine. Because mice studied in labs are bred in a controlled manner, they are often genetically identical. Most of the time this is beneficial. The lack of genetic variation increases reproducibility and can help researchers more quickly determine a contributing factor to disease, but research on more complex diseases calls for mice to be more like humans who are genetically diverse. That's where this research project differs from many others.
The researchers are studying mice from the Collaborative Cross Program. Because these mice more closely reflect the genetic variation of humans, they may be the key to understanding some of today's most common, and most complex, diseases. In this case, the specially bred mice were used to study the varying immune response to the annual influenza outbreak.
In this research project, the scientists studied 44 groups of flu-infected mice that varied genetically. Due to this variation, the mouse reaction to influenza varied greatly, just as it does in the human population. The researchers then noted genetic differences that may have caused the variety of disease responses. Their ongoing work is to more clearly identify which genes cause these differences.
"Each year, annual influenza epidemics result in about 3 million to 5 million cases of severe illness," explained Shannon McWeeney, Ph.D., an associate professor of biostatistics and bioinformatics and head of the Division of Bioinformatics and Computational Biology at OHSU. "We see a broad spectrum of response to influenza infection ranging from patients with minor symptoms to the estimated 250,000 to 500,000 deaths worldwide."
"We want to understand what genetic factors influence this wide-ranging response. More importantly, with a better understanding of the genetic influence of disease response, we believe we can help in the development of better, safer vaccines that can target the most vulnerable population: the sick, elderly and young. We also want to determine if the genetic factors that impact flu response also play a role in the varying responses to other diseases. If so, this new research method could have a much broader impact," McWeeney said.
The National Institute of Allergy and Infectious Diseases funded this research (5U54AI081680).
About OHSU (www.ohsu.edu)
Oregon Health & Science University is the state's only health and research university, and only academic health center. As Portland's largest employer and the fourth largest in Oregon (excluding government), OHSU's size contributes to its ability to provide many services and community support activities not found anywhere else in the state. OHSU serves patients from every corner of the state and is a conduit for learning for more than 4,300 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to each county in the state.
Jim Newman | EurekAlert!
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering